一个健康在人类特有病区控制法西奥利亚症
Santiago Mas-Coma1, M Adela Valero1, M Dolores Bargues1
1Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Av. Vicente Andrés Estellés s/n, 46100 Burjassot, - Valencia, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, C/Monforte de Lemos 3-5. Pabellón 11. Planta 0, 28029 Madrid, Spain.
Trends in parasitology
|June 29, 2023
概括
一个健康的方法对于控制复杂的肝脏病 - - 皮病至关重要. 整合环境,动物和人类健康战略有效降低了特有地区的传播风险.
科学领域:
- 兽医寄生虫学 兽医寄生虫学
- 公共卫生 公共卫生
- 环境科学 环境科学
背景情况:
- 由肝炎 *Fasciola hepatica* 和 *F. gigantica* 引起的羊病是全球重要的动物性传染病.
- 尽管进行预防性化疗,但人类的再感染在流行地区仍然存在,这是由牲畜水库和lymnaeid牛媒介驱动的.
- 对于有效的疾病控制,全面的"一健康"战略至关重要.
研究的目的:
- 概述一个多学科的"一个健康"框架,用于控制带病.
- 强调了解传输动态和环境因素的重要性.
- 倡导定制的,可持续的控制干预措施.
主要方法:
- 审查现有的流行病学和传播数据.
- 整合环境,生态和健康的社会决定因素.
- 开发一个整体的,一个健康控制战略框架.
主要成果:
- 有效的皮病控制需要一种多学科的方法来解决淡水焦点,牛载体,哺乳动物水库和人类行为的问题.
- 当地知识和定制干预措施是成功实施的关键.
- 根据影响和可用资金优先考虑控制措施,确保长期可持续性.
结论:
- 整合环境,动物和人类健康的一种健康方法是对抗皮病的最有效策略.
- 控制计划必须适应特定的特有环境,利用当地知识.
- 可持续的长期控制依赖于干预的战略优先级.
相关概念视频
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


